Study guide

16.3 Epidemiology of Hypertension, Diabetes & Cancer in India

Combined Medical Services Examination UPSC CMS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Logistics & Pattern

1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths

2 Chapter 2: General Medicine - Cardiology & Respiratory

2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism

3 Chapter 3: General Medicine - Gastroenterology & Hepatology

3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes

4 Chapter 4: General Medicine - Nephrology & Endocrinology

4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction

5 Chapter 5: General Medicine - Neurology, Haematology & Infection

5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue

6 Chapter 6: General Medicine - Emergency Medicine & Toxicology

6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology

7 Chapter 7: Paediatrics - Neonatology & Child Growth

7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones

8 Chapter 8: Paediatrics - Child Health & Nutrition

8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning

9 Chapter 9: Surgery - General Surgery, Wounds & Shock

9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery

10 Chapter 10: Surgery - Surgical Specialties I

10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi

11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia

11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease

12 Chapter 12: Obstetrics - Antenatal Care & Complications

12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management

13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH

13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care

14 Chapter 14: Gynaecology & Family Planning

14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods

15 Chapter 15: PSM - Epidemiology & Biostatistics

15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing

16 Chapter 16: PSM - Disease Epidemiology & Programmes

16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling

17 Chapter 17: PSM - Health Planning & Environmental Health

17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education

16.3 Epidemiology of Hypertension, Diabetes & Cancer in India

Key Takeaways Explain This Topic AI

Non-communicable diseases (NCDs) account for over 65% of total mortality in India, driven by the epidemiological transition and shared modifiable behavioral and metabolic risk factors.

The 'Rule of Halves' in hypertension epidemiology underscores that ~50% of hypertensives are diagnosed, ~50% of diagnosed receive treatment, and ~50% of treated achieve target blood pressure control.

India Hypertension Control Initiative (IHCI) enforces standardized drug protocols (Amlodipine step-up), uninterrupted drug supply, and patient tracking to achieve high population-level BP control.

Diabetes screening under the National Programme for Prevention and Control of NCDs (NP-NCD) target all adults aged ≥30 years using the Community Risk Assessment Checklist (CBAC score ≥4) and capillary blood glucose testing.

Visual Inspection with Acetic Acid (VIA) is the frontline population-based screening modality for cervical cancer in primary healthcare settings across India for women aged 30-65 years.

Last updated: July 2026

Epidemiology of Hypertension, Diabetes & Cancer in India

India is experiencing a rapid epidemiological transition. Non-communicable diseases (NCDs)—predominantly cardiovascular diseases, diabetes mellitus, cancers, and chronic respiratory diseases—now account for over 65% of all deaths in India. For the UPSC Combined Medical Services (CMS) exam, mastery of NCD epidemiological metrics, national screening protocols, and public health control initiatives is vital.

1. The Epidemiological Transition & Shared Risk Factors

Epidemiological Transition: Shift in disease burden from communicable, maternal, and nutritional conditions to chronic non-communicable diseases.

Shared Modifiable Behavioral Risk Factors: Tobacco use (smoked and smokeless), harmful alcohol consumption, unhealthy diet (high sodium >5 g/day, high trans-fats, low fruit/vegetable intake <400 g/day), and physical inactivity (<150 minutes of moderate-intensity aerobic exercise per week).

Shared Metabolic Risk Factors: Overweight/obesity (BMI ≥23 kg/m² for South Asians), elevated blood pressure, hyperglycemia, and hyperlipidemia.

Global & National Targets: WHO 25×25 Target (25% relative reduction in premature NCD mortality by 2025/2030) and the National NCD Monitoring Framework (10 targets and 21 indicators).

  • 2. Hypertension Epidemiology & The IHCI Framework
  • Disease Burden & The "Rule of Halves"

Prevalence in India: Affects approximately 28–30% of Indian adults (NFHS-5 data).

The Rule of Halves in Hypertension:

Only half of all individuals with hypertension are aware of their status (diagnosed).

Only half of those diagnosed receive medical treatment.

Only half of those treated achieve target blood pressure control (BP <140/90 mmHg).

Net Result: Only ~12.5% of all hypertensive individuals in an unmanaged population have controlled blood pressure.

Diagnostic Classifications (JNC-8 / ACC-AHA / ICMR Guidelines)

Normal Blood Pressure: Systolic <120 mmHg AND Diastolic <80 mmHg.

Elevated / Pre-hypertension: Systolic 120–129 mmHg AND Diastolic <80 mmHg.

Stage 1 Hypertension: Systolic 130–139 mmHg OR Diastolic 80–89 mmHg (ACC/AHA) / 140–159 / 90–99 mmHg (JNC-8/ICMR).

Stage 2 Hypertension: Systolic ≥140 mmHg OR Diastolic ≥90 mmHg (ACC/AHA) / ≥160 / ≥100 mmHg (JNC-8/ICMR).

India Hypertension Control Initiative (IHCI)

Launched to accelerate blood pressure control nationwide, IHCI relies on 5 Core Pillars :

Standardized Drug-Treatment Protocol: Simple step-up protocol using long-acting, once-daily antihypertensives.

Step 1: Initiate Amlodipine 5 mg once daily.

Step 2: Increase to Amlodipine 10 mg once daily if BP remains uncontrolled after 30 days.

Step 3: Add Telmisartan 40 mg once daily.

Step 4: Increase to Telmisartan 80 mg once daily.

Step 5: Add Chlorthalidone 12.5 mg or Hydrochlorothiazide 12.5 mg once daily.

Uninterrupted Drug Supply: Procurement of 3 primary protocol drugs at primary health centre level.

Team-Based Care: Task-sharing among Medical Officers, Staff Nurses, ANMs, and ASHAs.

Patient-Centered Services: 30-day drug refill policy and decentralization to Ayushman Arogya Mandirs (HWC).

Digital Information System: Patient tracking via simple digital registers / IHCI mobile application.

  • 3. Diabetes Mellitus Epidemiology & Population Control
  • Disease Burden in India (ICMR-INDIAB Study)

India is frequently termed the "Diabetes Capital of the World," with over 101 million adults living with diabetes and 136 million adults with prediabetes.

Urban prevalence (~16–20%) remains higher than rural (~8–10%), but rural prevalence is rapidly increasing.

Diagnostic Thresholds (ICMR / WHO Guidelines)

  • Category Fasting Plasma Glucose (FPG) 2-Hour 75g Oral Glucose Tolerance Test (OGTT) HbA1c Level
  • Normal < 100 mg/dL (5.6 mmol/L) < 140 mg/dL (7.8 mmol/L) < 5.7%

Prediabetes (IFG / IGT) 100–125 mg/dL (Impaired Fasting Glucose) 140–199 mg/dL (Impaired Glucose Tolerance) 5.7% – 6.4%

Diabetes Mellitus ≥ 126 mg/dL (7.0 mmol/L) ≥ 200 mg/dL (11.1 mmol/L) ≥ 6.5%

Random Blood Glucose: ≥200 mg/dL in the presence of classic hyperosmolar symptoms (polyuria, polydipsia, unexplained weight loss) is diagnostic of diabetes.

Population Screening under NP-NCD

Target Group: All adults aged ≥30 years presenting to primary healthcare facilities or screened in the community.

Tool: Community Based Risk Assessment Checklist (CBAC): Administered by ASHAs. Evaluates age, tobacco use, alcohol consumption, waist circumference, physical activity, and family history of NCDs. Individuals with a CBAC score ≥ 4 are prioritized for point-of-care Capillary Blood Glucose (CBG) testing using handheld glucometers.

  • 4. Cancer Epidemiology & Screening Protocols under NP-NCD
  • Epidemiology of Cancers in India

Males: Lip & Oral Cavity Cancer is the leading cancer site (due to widespread use of chewable smokeless tobacco products like gutka, khaini, and betel quid), followed by Lung, Stomach, and Esophagus cancers.

Females: Breast Cancer is the most common cancer site and leading cause of cancer mortality (surpassing cervical cancer in urban and semi-urban India), followed by Cervical Cancer and Oral Cavity cancer.

NP-NCD Population-Based Cancer Screening (PBS) Guidelines

Under the National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD), population-based screening for 3 common cancers (Cervical, Breast, Oral) is conducted at Ayushman Arogya Mandirs (Health & Wellness Centres) for all individuals aged 30 to 65 years every 5 years :

Cancer Type Target Group Frontline Screening Modality Key Clinical Procedure & Positive Finding

Cervical Cancer Women aged 30–65 years Visual Inspection with Acetic Acid (VIA) every 5 years Application of 3–5% freshly prepared dilute acetic acid to the cervix. Inspection after 1 minute: Appearance of an opaque, dense acetowhite lesion near the squamocolumnar junction indicates a POSITIVE test → Refer for Colposcopy / Cryotherapy.

Breast Cancer Women aged 30–65 years Clinical Breast Examination (CBE) every 5 years Systematic inspection and palpation of breasts and axillary lymph nodes by trained female health workers (ANMs/Nurses/MOs). Positive finding: Palpable hard painless mass, skin dimpling, or nipple retraction → Refer for Mammography / Ultrasound / FNAC.

Oral Cancer Men & Women aged ≥30 years Oral Visual Examination (OVE) every 5 years Systematic visual examination and bimanual palpation of the entire oral cavity under good light. Positive finding: Leukoplakia (white patch), Erythroplakia (red patch), or non-healing indurated ulcer >2 weeks → Refer for Biopsy.

Loading diagram... NP-NCD Population-Based Cancer Screening Protocol